Hepatitis B virus X protein is capable of down-regulating protein level of host antiviral protein APOBEC3G

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Chen, Ruidong ^a   Zhao, Xue ^a,b   Wang, Yongxiang ^a   Xie, Youhua ^a   Liu, Jing ^a  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI MUNICIPAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; HEPATITIS B VIRUS X PROTEIN; TRANSACTIVATOR PROTEIN;

EXOSOME; GENE EXPRESSION REGULATION; GENETICS; HEPATITIS B; HEPATITIS B VIRUS; HOST PATHOGEN INTERACTION; HUMAN; INTRACELLULAR SPACE; METABOLISM; PHYSIOLOGY; PROTEIN DEGRADATION; RNA PROCESSING; VIROLOGY;

APOBEC-3G DEAMINASE; EXOSOMES; GENE EXPRESSION REGULATION; HEPATITIS B; HEPATITIS B VIRUS; HOST-PATHOGEN INTERACTIONS; HUMANS; INTRACELLULAR SPACE; PROTEOLYSIS; RNA PROCESSING, POST-TRANSCRIPTIONAL; TRANS-ACTIVATORS;

EID: 85010078141     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep40783     Document Type: Article

References (44)

1. Seeger, C. & Mason, W. S. Hepatitis B virus biology. Microbiol Mol Biol Rev 64, 51-68 (2000).
2. Seeger, C. & Mason, W. S. Molecular biology of hepatitis B virus infection. Virology 479-480, 672-686, doi: 10.1016/j. virol.2015.02.031 (2015).
3. Liang, T. J. Hepatitis B: the virus and disease. Hepatology 49, S13-21, doi: 10.1002/hep.22881 (2009).
4. World Health Organization. Hepatitis B. World Health Organization Fact Sheet 204 (Revised July 2016). http://www.who.int/ mediacentre/factsheets/fs204/en/ (2016).
5. Protzer, U. Hepatitis: Epigenetic control of HBV by HBx protein-releasing the break? Nature reviews. Gastroenterology & hepatology 12, 558-559, doi: 10.1038/nrgastro.2015.152 (2015).
6. Guerrieri, F., Belloni, L., Pediconi, N. & Levrero, M. Molecular mechanisms of HBV-associated hepatocarcinogenesis. Semin Liver Dis 33, 147-156, doi: 10.1055/s-0033-1345721 (2013).
7. Lucifora, J. et al. Hepatitis B virus X protein is essential to initiate and maintain virus replication afer infection. J Hepatol 55, 996-1003, doi: 10.1016/j.jhep.2011.02.015 (2011).
8. Murakami, S. Hepatitis B virus X protein: a multifunctional viral regulator. J Gastroenterol 36, 651-660 (2001).
9. Tang, H. et al. The transcriptional transactivation function of HBx protein is important for its augmentation role in hepatitis B virus replication. Journal of virology 79, 5548-5556, doi: 10.1128/JVI.79.9.5548-5556.2005 (2005).
10. Zhao, X. et al. Quantitative Proteomic Analysis of Exosome Protein Content Changes Induced by Hepatitis B Virus in Huh-7 Cells Using SILAC Labeling and LC-MS/MS. J Proteome Res 13, 5391-5402, doi: 10.1021/pr5008703 (2014).
11. Slagle, B. L. & Bouchard, M. J. Hepatitis B Virus X and Regulation of Viral Gene Expression. Cold Spring Harbor perspectives in medicine 6, a021402, doi: 10.1101/cshperspect.a021402 (2016).
12. Salter, J. D., Bennett, R. P. & Smith, H. C. The APOBEC Protein Family: United by Structure, Divergent in Function. Trends Biochem Sci 41, 578-594, doi: 10.1016/j.tibs.2016.05.001 (2016).
13. Smith, H. C., Bennett, R. P. , Kizilyer, A., McDougall, W. M. & Prohaska, K. M. Functions and regulation of the APOBEC family of proteins. Semin Cell Dev Biol 23, 258-268, doi: 10.1016/j.semcdb.2011.10.004 (2012).
14. Harris, R. S. & Liddament, M. T. Retroviral restriction by APOBEC proteins. Nat Rev Immunol 4, 868-877, doi: 10.1038/nri1489 (2004).
15. Romani, B., Engelbrecht, S. & Glashof, R. H. Antiviral roles of APOBEC proteins against HIV-1 and suppression by Vif. Archives of virology 154, 1579-1588, doi: 10.1007/s00705-009-0481-y (2009).
16. Rosler, C., Kock, J., Malim, M. H., Blum, H. E. & von Weizsacker, F. Comment on "Inhibition of hepatitis B virus replication by APOBEC3G". Science 305, 1403, author reply 1403, doi: 10.1126/science.1100464 (2004).
17. Rosler, C. et al. APOBEC-mediated interference with hepadnavirus production. Hepatology 42, 301-309, doi: 10.1002/hep.20801 (2005).
18. Nguyen, D. H., Gummuluru, S. & Hu, J. Deamination-independent inhibition of hepatitis B virus reverse transcription by APOBEC3G. Journal of virology 81, 4465-4472, doi: 10.1128/JVI.02510-06 (2007).
19. Baumert, T. F., Rosler, C., Malim, M. H. & von Weizsacker, F. Hepatitis B virus DNA is subject to extensive editing by the human deaminase APOBEC3C. Hepatology 46, 682-689, doi: 10.1002/hep.21733 (2007).
20. Kock, J. & Blum, H. E. Hypermutation of hepatitis B virus genomes by APOBEC3G, APOBEC3C and APOBEC3H. The Journal of general virology 89, 1184-1191, doi: 10.1099/vir.0.83507-0 (2008).
21. Renard, M., Henry, M., Guetard, D., Vartanian, J. P. & Wain-Hobson, S. APOBEC1 and APOBEC3 cytidine deaminases as restriction factors for hepadnaviral genomes in non-humans in vivo. J Mol Biol 400, 323-334, doi: 10.1016/j.jmb.2010.05.029 (2010).
22. Vartanian, J. P. et al. Massive APOBEC3 editing of hepatitis B viral DNA in cirrhosis. PLoS Pathog 6, e1000928, doi: 10.1371/journal. ppat.1000928 (2010).
23. Ren, J., He, W. , Zheng, L. & Duan, H. From structures to functions: insights into exosomes as promising drug delivery vehicles. Biomaterials science 4, 910-921, doi: 10.1039/c5bm00583c (2016).
24. Turelli, P. , Mangeat, B., Jost, S., Vianin, S. & Trono, D. Inhibition of hepatitis B virus replication by APOBEC3G. Science 303, 1829, doi: 10.1126/science.1092066 (2004).
25. Trajkovic, K. et al. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 319, 1244-1247, doi: 10.1126/science.1153124 (2008).
26. Sheehy, A. M., Gaddis, N. C., Choi, J. D. & Malim, M. H. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418, 646-650, doi: 10.1038/nature00939 (2002).
27. Sheehy, A. M., Gaddis, N. C. & Malim, M. H. The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif. Nat Med 9, 1404-1407, doi: 10.1038/nm945 (2003).
28. Koning, F. A. et al. Defning APOBEC3 expression patterns in human tissues and hematopoietic cell subsets. Journal of virology 83, 9474-9485, doi: 10.1128/JVI.01089-09 (2009).
29. Sarkis, P. T., Ying, S., Xu, R. & Yu , X. F. STAT1-independent cell type-specifc regulation of antiviral APOBEC3G by IFN-alpha. J Immunol 177, 4530-4540, doi: 177/7/4530 [pii] (2006).
30. Bonvin, M. et al. Interferon-inducible expression of APOBEC3 editing enzymes in human hepatocytes and inhibition of hepatitis B virus replication. Hepatology 43, 1364-1374, doi: 10.1002/hep.21187 (2006).
31. Komohara, Y. et al. High expression of APOBEC3G in patients infected with hepatitis C virus. J Mol Histol 37, 327-332, doi: 10.1007/s10735-006-9059-0 (2006).
32. Tanaka, Y. et al. Anti-viral protein APOBEC3G is induced by interferon-alpha stimulation in human hepatocytes. Biochem Biophys Res Commun 341, 314-319, doi: 10.1016/j.bbrc.2005.12.192 (2006).
33. Jost, S., Turelli, P. , Mangeat, B., Protzer, U. & Trono, D. Induction of antiviral cytidine deaminases does not explain the inhibition of hepatitis B virus replication by interferons. Journal of virology 81, 10588-10596, doi: 10.1128/JVI.02489-06 (2007).
34. Suspene, R. et al. Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo. Proc Natl Acad Sci USA 102, 8321-8326, doi: 10.1073/pnas.0408223102 (2005).
35. Johnstone, R. M., Adam, M., Hammond, J. R., Orr, L. & Turbide, C. Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). The Journal of biological chemistry 262, 9412-9420 (1987).
36. Johnstone, R. M., Mathew, A., Mason, A. B. & Teng, K. Exosome formation during maturation of mammalian and avian reticulocytes: evidence that exosome release is a major route for externalization of obsolete membrane proteins. J Cell Physiol 147, 27-36, doi: 10.1002/jcp.1041470105 (1991).
37. Ahn, J. & Johnstone, R. M. Origin of a soluble truncated transferrin receptor. Blood 81, 2442-2451 (1993).
38. Chairoungdua, A., Smith, D. L., Pochard, P. , Hull, M. & Caplan, M. J. Exosome release of beta-catenin: a novel mechanism that antagonizes Wnt signaling. J Cell Biol 190, 1079-1091, doi: 10.1083/jcb.201002049 (2010).
39. Li, J. et al. Exosomes mediate the cell-to-cell transmission of IFN-alpha-induced antiviral activity. Nat Immunol 14, 793-803, doi: 10.1038/ni.2647 (2013).
40. Lambert, C., Doring, T. & Prange, R. Hepatitis B virus maturation is sensitive to functional inhibition of ESCRT-III, Vps4, and gamma 2-adaptin. Journal of virology 81, 9050-9060, doi: 10.1128/JVI.00479-07 (2007).
41. Watanabe, T. et al. Involvement of host cellular multivesicular body functions in hepatitis B virus budding. Proc Natl Acad Sci USA 104, 10205-10210, doi: 10.1073/pnas.0704000104 (2007).
42. Tellier, E. et al. Role for Furin in Tumor Necrosis Factor Alpha-Induced Activation of the Matrix Metalloproteinase/Sphingolipid Mitogenic Pathway. Molecular and Cellular Biology 27, 2997-3007, doi: 10.1128/MCB.01485-06 (2007).
43. Wei, L. et al. A broadly reactive monoclonal antibody detects multiple genotypes of hepatitis B virus X protein. Archives of virology 159, 2731-2735, doi: 10.1007/s00705-014-2111-6 (2014).
44. Hong, R. et al. Novel recombinant hepatitis B virus vectors efciently deliver protein and RNA encoding genes into primary hepatocytes. Journal of virology 87, 6615-6624, doi: 10.1128/JVI.03328-12 (2013).